EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Nano X Imaging Ltd (NNOX) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of Nano X Imaging Ltd $0.54, price $0.70, upside -22.0%, quality 27 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Healthcare · US · Home Israel · ISIN IL0011681371

NX Nano X Imaging Ltd logo Thin data Sep 23, 2026

Nano X Imaging Ltd

NNOX · US

Weak valuationQuality is weak on top of the rich price.

!Fair value $0.5440 · Overvalued (−22%)
!Quality 27/100
!Mixed Growth (revenue 3y +14.9 %/yr)
!Low debt · negative free cash flow
!Trails peers (3/8)
!Narrow moat 8/100
!Evidence only low, so the estimate is less certain
!Weak on valuation: 4 out of 100
Watch Nano X Imaging Ltd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$33.31 $0.6870 Fair Value $0.5440 Jun 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.

How to read this chart

60‑month range $0.6870 – $33.31 · fair‑value band $0.3570 – $0.6800 · the $0.6978 price screens above the $0.5440 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.

Follow Nano X Imaging in your weekly email

Every Wednesday you see whether Nano X Imaging is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications.

Show more

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data of existing computed tomography scans; and Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. In addition, the company provides Real+ Osteoporosis Care Management Platform, a osteoporosis care management software platform; AI-Based Aortic Valve Calcification Measurement, an artificial intelligence"based solution; AI-Based Body Composition Measurement, an artificial intelligence"based body composition analysis capability; and Nanox Health IT, a healthcare information technology services provider that serves hospitals and other healthcare organizations. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Petah Tikva, Israel.

Stock analysis

Nano X Imaging Ltd (NNOX) currently trades at $0.6978, while our model-based Fair Value estimate is $0.5440, implying the stock looks roughly 28.3% overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 95/100, which puts the evidence level at low.

Scenario range: $0.3570 (bear) to $0.6800 (bull), the price of $0.6978 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 27/100 (below-average quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Nano X Imaging Ltd reported revenue of $13.0M in FY2025 versus $1.3M in FY2021, a compound +77.8%/yr. Reported net income was −$75.0M in FY2025.

Key figures

Market cap $116M · P/S ratio 8.93 · EPS (TTM) $−1.16 · Return on equity −45.6% · Return on assets (EBIT) −30.6% · Operating margin −479% · Revenue (TTM) $13.0M · Revenue growth (YoY) +24.0%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 27 out of 100 (medium confidence).

What moves the price

The share trades about 85% below its 52-week high and 2% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 5% fair-value upside, at −22%, NNOX screens richer than that median.

Fair Value models

Bear $0.3570 Fair Value $0.5440 Bull $0.6800
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
NCAV (Graham) $1.00 $1.35 $2.01 54
All 1 models by family
Asset-Based
NCAV (Graham) $1.00 $1.35 $2.01 54

Open the full fair value analysis →

Notify me when NNOX reaches fair value

Put NNOX on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 27/100

Of which business quality 30 · Market factors (momentum, volatility) 7

Profitability 0
Margins and returns on capital today
Quality Growth 48
Are margins and returns improving?
Cashflow 1
Earnings quality: real cash, not paper profit
Fin. Strength 74
Balance sheet, leverage, solvency risk
Investment 67
Disciplined investing over empire-building
Low Volatility 24
Calm price path (market factor)
Momentum 0
Price trend over the last 3–12 months (market factor)
52W Momentum 0
Distance to the 52-week high (market factor)
Net Issuance 2
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 26/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+15.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.9%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−4,720.7% (2021) → −466.2% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

NNOX screens 28% overvalued. Compare with Abbott Laboratories, →

Compare Nano X Imaging Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 365 stocks

Beats the industry median on 3/7 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 30 · Bottom 25%
Fair Value upside −22% · Below median
Profitability
Return on assets −20% · Bottom 25%
Growth and dividend
Revenue growth 24% · Top 25%
Balance sheet
Debt / equity 0.03× · Below median

Valuation Multiplesvs Medical Devices median · lower = cheaper

P/B 0.83× · Cheaper than median
P/S (TTM) 8.93× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)4 · sector 10
FUTURE (revenue growth)100 · sector 31
PAST (return on equity)0 · sector 7
HEALTH (low debt)99 · sector 97
DIVIDEND (yield)0 · sector 40

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Devices stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Abbott Laboratories, ABT $103.49 $74.79 −28%
Stryker Corporation SYK $273.40 $300.74 +10%
Medtronic plc MDT $89.30 $65.57 −27%
Boston Scientific Corporation BSX $44.62 $49.08 +10%
Edwards Lifesciences Corporation EW $86.82 $82.04 −6%
Siemens Healthineers AG SHL €37.21 €35.22 −5%
DexCom, Inc DXCM $87.73 $96.50 +10%
GE HealthCare Technologies Inc GEHC $66.27 $69.62 +5%
Shenzhen Mindray Bio-Medical Electronics Co 300760 ¥156.68 ¥172.35 +10%
Koninklijke Philips N.V PHIA €21.85 €15.32 −30%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Nano X Imaging Ltd · Fair Value
$0.5440 −28%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Nano X Imaging Ltd Fair Value". https://www.fairvalue-calculator.com/stock/NNOX

Frequently asked questions

Is Nano X Imaging Ltd (NNOX) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of $0.5440 versus a price of $0.6978, about −22% upside (overvalued).
What is the fair value of NNOX?
Our model-based fair value for Nano X Imaging Ltd is $0.5440 (as of Sep 23, 2026), built from audited fundamentals. The current price: $0.6978.
What is the quality score of NNOX?
Nano X Imaging Ltd has a Quality Score of 27/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Nano X Imaging Ltd (NNOX)?
Our model-based price target is the fair value of $0.5440 (as of Sep 23, 2026) from 1 valuation models. Cautious scenario $0.3570, optimistic scenario $0.6800. It is a calculation from audited fundamentals, not an analyst target.
What is the Nano X Imaging Ltd stock forecast for 2026?
Our models put fair value at $0.5440, about −22% upside versus a price of $0.6978 (overvalued). Cautious scenario $0.3570, optimistic scenario $0.6800. The calculation is refreshed regularly with new filings.
What is the revenue of Nano X Imaging Ltd (NNOX)?
Nano X Imaging Ltd reported trailing-twelve-month revenue of about $13.0M (latest available figure, as of Sep 23, 2026).
What is the intrinsic value of Nano X Imaging Ltd (NNOX)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Nano X Imaging Ltd it is $0.5440 per share (as of Sep 23, 2026), against a price of $0.6978. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Nano X Imaging Ltd stock overvalued or undervalued in 2026?
As of Sep 23, 2026, NNOX trades above its calculated fair value: price $0.6978, fair value $0.5440, a gap of about −22% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of NNOX?
No. The price is what the market pays today ($0.6978); the fair value is what the company's own numbers justify ($0.5440). For Nano X Imaging Ltd the two are $0.1538 per share apart. That gap is exactly why we show both numbers side by side.
How much is Nano X Imaging Ltd worth?
The market values Nano X Imaging Ltd at about $116M (market capitalisation, as of Sep 23, 2026). Per share that is $0.6978; our models calculate a fair value of $0.5440 per share.
What do the bullish and bearish scenarios say about NNOX?
Our models span a range for Nano X Imaging Ltd: cautious scenario $0.3570, base $0.5440, optimistic $0.6800 per share (as of Sep 23, 2026, price $0.6978). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Nano X Imaging Ltd (NNOX)?
Balance-sheet figures for Nano X Imaging Ltd (as of Sep 23, 2026): return on equity −45.6%, debt of 0.03 per unit of equity. They feed the Quality Score of 27/100, which measures business quality independently of the share price.
How far is NNOX from its 52-week high?
Nano X Imaging Ltd trades at $0.6978, about 85% below its 52-week high of $4.55 and 2% above the low of $0.6870 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of $0.5440 is for.
Which stocks are comparable to Nano X Imaging Ltd?
From the same area (Healthcare) we also value Abbott Laboratories,, Stryker Corporation, Medtronic plc, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Nano X Imaging Ltd stock attractive at the current price?
The data as of Sep 23, 2026: price $0.6978, calculated fair value $0.5440 (−22%), Quality Score 27/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of NNOX calculated?
We run Nano X Imaging Ltd through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.5440, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Nano X Imaging Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Nano X Imaging Ltd (NNOX)?
The closing price on Sep 23, 2026 was $0.6978. Our model-based fair value is $0.5440, about −22% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Nano X Imaging Ltd right now?
The price sits above even our optimistic bull case ($0.6800). The favourable scenario is already priced in. Weak quality (27/100) and above fair value at the same time, the margin of safety is missing on both counts. A fairly wide model range ($0.3570 to $0.6800) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Nano X Imaging Ltd

How large is the market capitalisation of Nano X Imaging Ltd (NNOX)?
The market capitalisation of Nano X Imaging Ltd is $116M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Nano X Imaging Ltd (NNOX)?
The price-to-sales ratio of Nano X Imaging Ltd is 8.93 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Nano X Imaging Ltd (NNOX)?
Earnings per share at Nano X Imaging Ltd are $−1.16. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Nano X Imaging Ltd (NNOX)?
The return on equity (ROE) of Nano X Imaging Ltd is −45.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Nano X Imaging Ltd (NNOX)?
On an EBIT basis the return on assets of Nano X Imaging Ltd is −30.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Nano X Imaging Ltd (NNOX)?
The operating margin of Nano X Imaging Ltd is −479% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Nano X Imaging Ltd (NNOX)?
Revenue at Nano X Imaging Ltd is growing +24.0% versus a year earlier (3y avg +14.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Nano X Imaging Ltd (NNOX) generate?
The free cash flow of Nano X Imaging Ltd is −$45.0M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Nano X Imaging Ltd (NNOX) hold?
Nano X Imaging Ltd holds more cash than debt, $41.3M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Nano X Imaging Ltd in the live analysis

One click puts Nano X Imaging Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.